Retatrutide, by Soma Pharmaceuticals , is attracting considerable attention as a innovative treatment for metabolic control . This innovative compound combines the mechanism of a GLP-1 receptor stimulant and a GIP receptor stimulant, aiming to not only promote metabolic improvements but also addr